bf/NASDAQ:DTIL_icon.png

COM:PRECISIONBIOSCIENCES

Precision BioSciences, Inc.

  • Stock

USD

Last Close

6.50

22/11 21:00

Market Cap

67.46M

Beta: -

Volume Today

105.61K

Avg: -

Company Overview

Metric
Company NamePrecision BioSciences, Inc.
SymbolDTIL
MSH IDCOM:PRECISIONBIOSCIENCES
MarketSTOCKS
SectorHealthcare
IndustryBiotechnology
CountryUS
Stage
Employee Count109
Websiteprecisionbiosciences.com
LinkedInprecision-biosciences-inc-
Founders

Market Metrics

Metric
Market Cap67.46M
Enterprise Value
Monthly Web Traffic3.94K
Web Traffic Growth-0.02
Valuation
Raised Capital40M

Financial Performance

Metric
Revenue48.73M
Revenue (LTM)
Revenue (NTM)
Gross Profit48.73M
EBITDA-42.53M
Operating Income-42.53M
Net Income-61.32M
EPS-0.02
Diluted EPS-0.02
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.93
Operating Profit Margin-0.08
EBITDA Margin-0.87
Net Profit Margin0.19
Return on Equity0.42
Return on Assets0.10
Return on Capital Employed-0.05

Valuation Multiples

Metric
P/E Ratio-0.56
P/B Ratio1.54
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.59
EV Multiple-2.63

Operational Metrics

Metric
Days Sales Outstanding24.50
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle95.87
Cash Conversion Cycle28.39
Asset Turnover0.53

Cash Flow Metrics

Metric
Operating Cash Flow-84.11M
Free Cash Flow-86.07M
Cash Flow to Debt-2.12
Operating Cash Flow/Sales-0.75
Free Cash Flow Yield-1.50

Balance Sheet Metrics

Metric
Cash & Equivalents116.68M
Accounts Receivable-181K
Inventory
Goodwill
Debt to Capitalization0.62
Debt to Assets0.01
Current Ratio2.88
Quick Ratio4.82

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.33
R&D to Revenue1.55
SG&A to Revenue0.78